2seventy bio

Cambridge, United States

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

$125.0M raised

Feb 2023

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has 2seventy bio raised?

2seventy bio has raised $125.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2023.

Who are 2seventy bio's investors?

2seventy bio's investors include Janus Henderson Investors, RTW Investments, Bain Capital Life Sciences, Regeneron, EcoR1 Capital.

Where is 2seventy bio headquartered?

2seventy bio is headquartered in Cambridge, United States.

What does 2seventy bio do?

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

What stage is 2seventy bio at?

2seventy bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2023.

MLA

"2seventy bio — Funding & Investors." VCBacked, February 28, 2023, https://www.vcbacked.co/company/2seventy-bio. Accessed July 2, 2026.

APA

VCBacked. (2023). 2seventy bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/2seventy-bio

Wikipedia (cite web)

{{cite web |title=2seventy bio — Funding & Investors |url=https://www.vcbacked.co/company/2seventy-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2023.